ACRIVON THERAPEUTICS: ENTERED DEAL TERMINATING FUTURE ROYALTY, MILESTONE OBLIGATIONS ON ACR-525 PREVIOUSLY AGREED BETWEEN AQILION & LEO PHARMA

Reuters · 2d ago

Please log in to view news